168 related articles for article (PubMed ID: 35345391)
1. Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020.
Thean LJ; Romani L; Engelman D; Wand H; Jenney A; Mani J; Paka J; Cua T; Taole S; Silai M; Ashwini K; Sahukhan A; Kama M; Tuicakau M; Kado J; Parnaby M; Carvalho N; Whitfeld M; Kaldor J; Steer AC
Lancet Reg Health West Pac; 2022 May; 22():100433. PubMed ID: 35345391
[TBL] [Abstract][Full Text] [Related]
2. The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipalities in Timor-Leste: a before-after assessment.
Le B; Monteiro MAA; Amaral S; Wand H; Matthews A; Hii SF; Clarke NE; Arkell P; Yan J; Engelman D; Fancourt N; Fernandes JL; Steer A; Kaldor J; Traub R; Francis JR; Nery SV
Lancet Glob Health; 2023 Jun; 11(6):e924-e932. PubMed ID: 37202027
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial.
Romani L; Marks M; Sokana O; Nasi T; Kamoriki B; Cordell B; Wand H; Whitfeld MJ; Engelman D; Solomon AW; Kaldor JM; Steer AC
Lancet Infect Dis; 2019 May; 19(5):510-518. PubMed ID: 30956111
[TBL] [Abstract][Full Text] [Related]
4. Mass Drug Administration for Scabies Control in a Population with Endemic Disease.
Romani L; Whitfeld MJ; Koroivueta J; Kama M; Wand H; Tikoduadua L; Tuicakau M; Koroi A; Andrews R; Kaldor JM; Steer AC
N Engl J Med; 2015 Dec; 373(24):2305-13. PubMed ID: 26650152
[TBL] [Abstract][Full Text] [Related]
5. Prospective Surveillance of Primary Healthcare Presentations for Scabies and Bacterial Skin Infections in Fiji, 2018-2019.
Thean LJ; Romani L; Engelman D; Jenney A; Wand H; Mani J; Paka J; Devi R; Sahukhan A; Kama M; Tuicakau M; Kado J; Carvalho N; Whitfeld M; Kaldor J; Steer AC
Am J Trop Med Hyg; 2021 May; 105(1):230-237. PubMed ID: 34029210
[TBL] [Abstract][Full Text] [Related]
6. Community control strategies for scabies: A cluster randomised noninferiority trial.
Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Schuster T; Grobler AC; Engelman D; Robinson LJ; Kaldor JM; Steer AC
PLoS Med; 2021 Nov; 18(11):e1003849. PubMed ID: 34758017
[TBL] [Abstract][Full Text] [Related]
7. Control of scabies in a tribal community using mass screening and treatment with oral ivermectin -A cluster randomized controlled trial in Gadchiroli, India.
Behera P; Munshi H; Kalkonde Y; Deshmukh M; Bang A
PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009330. PubMed ID: 33861741
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and Azithromycin.
Marks M; Romani L; Sokana O; Neko L; Harrington R; Nasi T; Wand H; Whitfeld MJ; Engelman D; Solomon AW; Kaldor JM; Steer AC
Clin Infect Dis; 2020 Apr; 70(8):1591-1595. PubMed ID: 31131410
[TBL] [Abstract][Full Text] [Related]
9. Hospital admissions for skin and soft tissue infections in a population with endemic scabies: A prospective study in Fiji, 2018-2019.
Thean LJ; Jenney A; Engelman D; Romani L; Wand H; Mudaliar J; Paka J; Cua T; Taole S; Sahukhan A; Kama M; Tuicakau M; Kado J; Carvalho N; Whitfeld M; Kaldor J; Steer AC
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008887. PubMed ID: 33296378
[TBL] [Abstract][Full Text] [Related]
10. Mass Drug Administration for the Control of Scabies: A Systematic Review and Meta-analysis.
Lake SJ; Kaldor JM; Hardy M; Engelman D; Steer AC; Romani L
Clin Infect Dis; 2022 Sep; 75(6):959-967. PubMed ID: 35088849
[TBL] [Abstract][Full Text] [Related]
11. Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study).
Lake SJ; Phelan SL; Engelman D; Sokana O; Nasi T; Boara D; Gorae C; Schuster T; Grobler AC; Osti MH; Andrews R; Marks M; Whitfeld MJ; Romani L; Kaldor J; Steer A
BMJ Open; 2020 Aug; 10(8):e037305. PubMed ID: 32868360
[TBL] [Abstract][Full Text] [Related]
12. One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trial.
Lake SJ; Engelman D; Zinihite J; Sokana O; Boara D; Nasi T; Gorae C; Osti MH; Phelan S; Parnaby M; Grobler AC; Schuster T; Andrews R; Whitfeld MJ; Marks M; Romani L; Steer AC; Kaldor JM
PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011207. PubMed ID: 36930667
[TBL] [Abstract][Full Text] [Related]
13. Randomized Trial of Community Treatment With Azithromycin and Ivermectin Mass Drug Administration for Control of Scabies and Impetigo.
Marks M; Toloka H; Baker C; Kositz C; Asugeni J; Puiahi E; Asugeni R; Azzopardi K; Diau J; Kaldor JM; Romani L; Redman-MacLaren M; MacLaren D; Solomon AW; Mabey DCW; Steer AC
Clin Infect Dis; 2019 Mar; 68(6):927-933. PubMed ID: 29985978
[TBL] [Abstract][Full Text] [Related]
14. Community perspectives on scabies, impetigo and mass drug administration in Fiji: A qualitative study.
Mitchell E; Bell S; Thean LJ; Sahukhan A; Kama M; Koroivueti A; Kaldor J; Steer A; Romani L
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008825. PubMed ID: 33275592
[TBL] [Abstract][Full Text] [Related]
15. Are scabies and impetigo "normalised"? A cross-sectional comparative study of hospitalised children in northern Australia assessing clinical recognition and treatment of skin infections.
Yeoh DK; Anderson A; Cleland G; Bowen AC
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005726. PubMed ID: 28671945
[TBL] [Abstract][Full Text] [Related]
16. The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.
Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Grobler AC; Robinson LJ; Kaldor JM; Steer AC
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008106. PubMed ID: 32176703
[TBL] [Abstract][Full Text] [Related]
17. Prospective surveillance for invasive Staphylococcus aureus and group A Streptococcus infections in a setting with high community burden of scabies and impetigo.
Thean LJ; Jenney A; Engelman D; Romani L; Wand H; Mani J; Paka J; Cua T; Taole S; Soqo V; Sahukhan A; Kama M; Tuicakau M; Kado J; Carvalho N; Whitfeld M; Kaldor J; Steer AC
Int J Infect Dis; 2021 Jul; 108():333-339. PubMed ID: 34022330
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of scabies and impetigo in school-age children in Timor-Leste.
Matthews A; Le B; Amaral S; Arkell P; Monteiro M; Clarke N; Barros T; de Jesus Mendonça J; Gusmão SME; Dos Reis Seixas LM; da Piedade JHA; Engelman D; Steer AC; Fancourt NSS; Yan J; Kaldor J; Francis JR; Nery SV
Parasit Vectors; 2021 Mar; 14(1):156. PubMed ID: 33722285
[TBL] [Abstract][Full Text] [Related]
19. Scabies and impetigo prevalence and risk factors in Fiji: a national survey.
Romani L; Koroivueta J; Steer AC; Kama M; Kaldor JM; Wand H; Hamid M; Whitfeld MJ
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003452. PubMed ID: 25738499
[TBL] [Abstract][Full Text] [Related]
20. The Epidemiology of Scabies and Impetigo in Relation to Demographic and Residential Characteristics: Baseline Findings from the Skin Health Intervention Fiji Trial.
Romani L; Whitfeld MJ; Koroivueta J; Kama M; Wand H; Tikoduadua L; Tuicakau M; Koroi A; Ritova R; Andrews R; Kaldor JM; Steer AC
Am J Trop Med Hyg; 2017 Sep; 97(3):845-850. PubMed ID: 28722612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
